Summary: Benzinga considers the potential of psilocybin- and MDMA-assisted therapy as treatment options for individuals with autism spectrum disorders, drawing on previous MAPS-sponsored research of MDMA-assisted …
As long as I can remember, I had a wonderful childhood. Memories of me with my family barbecuing and learning how to bike, swimming for the first time without floaters thanks to my friends help, a van …
On October 29, 2021, staff members from the MAPS Public Benefit Corporation (MAPS PBC) conducted a site initiation visit (SIV) for our intermediate-size multi-site expanded access program for MDMA-assisted …
We are currently seeking research volunteers for our second Phase 3 clinical trial of MDMA-assisted therapy for PTSD. We’ve already accrued about 57 of the 100 subjects needed so potential volunteers …
On October 4, 2021, Dr. Anne Wagner and a team of researchers at Remedy Institute in Toronto, Ontario, Canada, began studying MDMA-assisted cognitive processing therapy (CPT) for individuals with posttraumatic …
After 31 years since MAPS first tried to start research into MDMA-assisted therapy for PTSD inside the Veterans Affairs (VA) system, the first study participant has been enrolled in an investigator-initiated …
Dr. Benjamin Kelmendi and a team of researchers at Yale University in New Haven, Connecticut, are studying the effects of MDMA on prefrontal and amygdala activation in individuals with posttraumatic stress …
Dr. Leanne Williams and a team of researchers at Stanford University in Stanford, California, are using fMRI to studyhow MDMA impacts the reward circuits of the human brain of healthy individuals.. This …
The fall MDMA Therapy Training cohort is now underway and includes 520 trainees in a 100-hour online program, running through December 18. So far this year we’ve granted $900,000 in 231 Health Equity …
In September 2021, over 1,400 donors gave $535,588 in donations and pledges. We are so grateful to these supporters who advance our shared vision of creating safe and legal opportunities for the beneficial …
Summary: Verywell Health explores the potential impact that psychedelics could have on healing trauma caused by the COVID-19 pandemic in an interview with MAPS Founder Rick Doblin, Ph.D. “Doblin …
We are currently seeking research volunteers for our second Phase 3 clinical trial of MDMA-assisted therapy for PTSD. Volunteers must have PTSD and live in an area close to a study site. People of color …
